Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 9:34 pm Sale |
2022-12-31 | 13G | Tango Therapeutics, Inc. TNGX |
Casdin Capital, LLC | 0 0.000% |
-5,487,910 (Position Closed) |
Filing History |
| 2023-02-09 12:39 pm Purchase |
2023-02-09 | 13G | Tango Therapeutics, Inc. TNGX |
FMR CORP | 9,083,679 8.291% |
1,901,491 (+26.48%) |
Filing History |
| 2022-07-11 4:01 pm Purchase |
2022-06-30 | 13G | Tango Therapeutics, Inc. TNGX |
Southpoint Master Fund, LP | 4,500,000 5.100% |
1,500,000 (+50.00%) |
Filing History |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | Tango Therapeutics, Inc. TNGX |
RA Capital Management, L.P. | 2,250,000 2.600% |
2,250,000 (New Position) |
Filing History |
| 2022-02-14 3:17 pm Purchase |
2021-12-31 | 13G | Tango Therapeutics, Inc. TNGX |
Cormorant Asset Management LP | 4,899,184 5.600% |
4,899,184 (New Position) |
Filing History |
| 2022-02-10 4:31 pm Purchase |
2021-12-31 | 13G | Tango Therapeutics, Inc. TNGX |
Southpoint Master Fund, LP | 3,000,000 3.400% |
3,000,000 (New Position) |
Filing History |
| 2022-02-09 10:01 am Purchase |
2022-02-08 | 13G | Tango Therapeutics, Inc. TNGX |
FMR CORP | 7,182,188 6.593% |
7,182,188 (New Position) |
Filing History |
| 2022-01-04 5:03 pm Unchanged |
2021-08-10 | 13D | Tango Therapeutics, Inc. TNGX |
BCTG Holdings, LLC | 6,988,450 8.000% |
0 (Unchanged) |
Filing History |
| 2021-09-10 12:17 pm Purchase |
2021-08-10 | 13G | Tango Therapeutics, Inc. TNGX |
GILEAD SCIENCES INC GILD |
4,854,443 5.500% |
4,854,443 (New Position) |
Filing History |
| 2021-08-20 4:31 pm Purchase |
2021-08-10 | 13D | Tango Therapeutics, Inc. TNGX |
BCTG Holdings, LLC | 6,988,450 8.300% |
6,988,450 (New Position) |
Filing History |
| 2021-08-19 4:59 pm Purchase |
2021-08-10 | 13G | Tango Therapeutics, Inc. TNGX |
Casdin Capital, LLC | 5,487,910 6.300% |
5,487,910 (New Position) |
Filing History |
| 2021-08-19 4:35 pm Purchase |
2021-08-10 | 13D | Tango Therapeutics, Inc. TNGX |
Third Rock Ventures IV L.P. | 19,363,975 22.100% |
19,363,975 (New Position) |
Filing History |
| 2021-04-26 4:30 pm Purchase |
2021-04-14 | 13G | BCTG Acquisition Corp. BCTG |
Southpoint Master Fund, LP | 1,906,380 8.900% |
1,906,380 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | BCTG Acquisition Corp. BCTG |
RA Capital Management, L.P. | 1,250,000 5.800% |
1,250,000 (New Position) |
Filing History |
| 2021-02-16 4:35 pm Purchase |
2020-12-31 | 13G | BCTG Acquisition Corp. BCTG |
BCTG Holdings, LLC | 4,488,450 21.000% |
4,488,450 (New Position) |
Filing History |